Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06933914 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Long-term Safety and Tolerability of MY008211A Tablets in Patients With Paroxysmal Nocturnal Hemoglobinuria

StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a multicenter, single-arm, open-label study to characterize long-term safety and tolerability of MY008211A tablets and to provide access to MY008211A tablets to patients with PNH who have completed Phase 2 or 3 studies with MY008211A tablets.
Trial Details
NCT Number NCT06933914
Lead Sponsor Wuhan Createrna Science and Technology Co., Ltd
Conditions
(from sponsor)		 Paroxysmal Nocturnal Hemoglobinuria (PNH)
Related terms Hemoglobinuria, Paroxysmal
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov